Home » Urological Surgery and Treatments » Late-Onset Hypogonadism (LOH)
Late-onset hypogonadism (LOH) is characterized by a progressive decline in blood testosterone levels associated with advancing age in men.
Unlike female menopause — which involves a sudden and complete halt in hormone production and fertility —, this condition in men occurs slowly, insidiously, and gradually, which is why the popularly used term “andropause” is not appropriate. From the age of 30 to 40, total testosterone levels undergo a natural physiological decline of about 1% per year. In many men, this decline does not cause problems, but when hormone levels fall below the healthy threshold, clinical symptoms with systemic impact begin to appear.
Testosterone plays a vital role in multiple organs of the male body. LOH manifests through a triad of physical, sexual, and psychological symptoms:
The diagnosis of LOH can never be based on symptoms alone (which are common to stress and general aging). It requires confirmation through specific blood tests.
In cases where the hormone deficiency is clinically and laboratorially confirmed, **Testosterone Replacement Therapy (TRT)** offers extraordinary benefits in restoring vitality and overall health in men.
The main modern methods of administration include:
Safety and Medical Monitoring: TRT is a safe medical treatment, but it requires rigorous urological monitoring. Before and during treatment, the urologist must periodically assess hemoglobin levels (risk of polycythemia), liver function, and prostate status through a digital rectal exam and **PSA** testing. TRT does not cause prostate cancer; however, prior exclusion of existing cancer is recommended.
Book your urology appointment with Dr Frederico Furriel, a urologist with consultations in Leiria, Caldas da Rainha and Porto de Mós. Select your preferred location and submit your appointment request.